找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Complications in Uveitis; Francesco Pichi,Piergiorgio Neri Book 2020 Springer Nature Switzerland AG 2020 Uveitic cataract.Uveitic glaucoma

[復(fù)制鏈接]
樓主: Addendum
21#
發(fā)表于 2025-3-25 03:21:00 | 只看該作者
Kelly A. Davis,Krzysztof Matyjaszewskie achievement of high-resolution images, useful in distinguishing subtle changes in the anatomy and pathology of structures like the retroiridal face, CB, and pars plana (PP), which are not precisely accessible by routine USG. This technology has a tissue depth penetration of approximately 3–6 mm an
22#
發(fā)表于 2025-3-25 07:44:02 | 只看該作者
23#
發(fā)表于 2025-3-25 15:34:50 | 只看該作者
24#
發(fā)表于 2025-3-25 17:28:25 | 只看該作者
Ciliary Processes Complications from Uveitise achievement of high-resolution images, useful in distinguishing subtle changes in the anatomy and pathology of structures like the retroiridal face, CB, and pars plana (PP), which are not precisely accessible by routine USG. This technology has a tissue depth penetration of approximately 3–6 mm an
25#
發(fā)表于 2025-3-25 22:19:06 | 只看該作者
26#
發(fā)表于 2025-3-26 03:40:40 | 只看該作者
Treatment of Inflammatory Choroidal Neovascular Membranestion control. The association of steroids with immunosuppressive agents is most appropriate therapy for inflammatory CNV. Anti-VEGF agents are commonly associated with systemic therapy..Although there is no comparative study between immunosuppressive agents, mycophenolate mofetil seems to offer a pr
27#
發(fā)表于 2025-3-26 06:44:33 | 只看該作者
bemanagement of the complication. This multi-disciplinary approach to complications of uveitis will provide to the readers the tools to prevent them, or to correctly manage the. It will be a book mainly directe978-3-030-28394-0978-3-030-28392-6
28#
發(fā)表于 2025-3-26 09:54:52 | 只看該作者
Limbal Stem Cell Deficiency in Inflammatory Disordersration onto the cornea (conjunctivalization) with severe visual impairment. Lamellar and/or penetrating keratoplasty cannot be successful as donor corneal epithelium is replaced by that of the recipient within months. In the presence of LSCD graft re-epithelialisation will not take place, with subse
29#
發(fā)表于 2025-3-26 16:06:37 | 只看該作者
30#
發(fā)表于 2025-3-26 19:52:28 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 12:26
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
南陵县| 逊克县| 东丰县| 逊克县| 昌江| 高要市| 通榆县| 黄浦区| 青田县| 宿州市| 惠来县| 万荣县| 河东区| 靖安县| 静乐县| 天柱县| 三河市| 治多县| 满洲里市| 无棣县| 金昌市| 博客| 屏山县| 永靖县| 永仁县| 大埔县| 广灵县| 若尔盖县| 屏东县| 交城县| 扬州市| 樟树市| 宜城市| 乌兰县| 郸城县| 昭苏县| 建昌县| 延吉市| 诏安县| 泰宁县| 舒兰市|